Minghui Duan

19PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 29, 2026
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.

|Jul 03, 2025
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F-Positive Myeloproliferative Neoplasms.

Guangshuai Teng, Ke Shang, Yuhui Zhang

|Dec 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Rong Wang, Zhongxun Shi, Yuan Zhang

|Nov 08, 2024
BRAF Deletion in Adult Patients with Langerhans Cell Histiocytosis Correlates with Multisystem Disease and Poor Outcomes.

Min Lang, Long Chang, Hao Cai

|Oct 21, 2024
Long-term follow-up of methotrexate and cytarabine in adult patients with Langerhans cell histiocytosis.

He Lin, Long Chang, Min Lang

|Oct 15, 2024
Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single-centre, retrospective study.

Yu-Han Gao, Si-Yuan Li, Yue Dang

Pageof 4

Frequent Collaborators

11 joint publications

Jian Li

9 joint publications

Xin-Xin Cao

7 joint publications

Dao-Bin Zhou

5 joint publications

Lu Zhang